Dr. Dorothy Auth has more than 20 years of experience in complex patent litigation, as well as licensing, patent procurement, and intellectual property counseling in the United States and abroad. Her experience spans diverse industries, including biotechnology, pharmaceutical, and medical devices, as well as consumer products, computers, and other mechanical devices.
She addresses intellectual property diligence issues surrounding mergers, acquisitions, and bankruptcies. Representative clients in transactional IP matters includes the U.S. Treasury, Salix Pharmaceuticals, Ltd., Pfizer; Elan Pharmaceutical, Healthcare Royalty Partners; Fountanbleu Hotel; Quart Rx Pharma; iShares; Towers Watson; Hess and Triarco. In the transactional area, Dorothy advises clients on the validity of garget patents as well as performing clearance analysis on the patents of competitors to render freedom-to-operate opinions.
Articles in the National Law Review database by Dorothy R. Auth Ph.D.